Pentoxifylline inhibits integrin-mediated adherence of 12(S)-HETE and TNFalpha-activated B16F10 cells to fibronectin and endothelial cells.
Jain
Meenakashi
M
Advanced Centre for Treatment, Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
Ratheesh
Aparna
A
Gude
Rajiv P
RP
D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002448:Cell Adhesion / Q000187:drug effects*; D045744:Cell Line, Tumor; D042783:Endothelial Cells / Q000166:cytology; D005353:Fibronectins / Q000378:metabolism; D016023:Integrins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008546:Melanoma, Experimental / Q000473:pathology; D051379:Mice; D010431:Pentoxifylline / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000031:analogs & derivatives / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D000970:Antineoplastic Agents; D005353:Fibronectins; D016023:Integrins; D010726:Phosphodiesterase Inhibitors; D014409:Tumor Necrosis Factor-alpha; C020922:4-O-methyl-12-O-tetradecanoylphorbol 13-acetate; D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; D013755:Tetradecanoylphorbol Acetate; D010431:Pentoxifylline